Aurinia Pharmaceuticals Inc. - Filer Information

Symbol
AUPH on Nasdaq
Entity
Company
CIK
0001600620
EIN
981231763
Business address
#140, 14315 118 Avenue, T5L 4S6 Edmonton, Alberta, Canada
Phone
250-744-2487
Fiscal year end
December 31
Category
Large accelerated filer
All SEC filings
View on sec.gov
Get insider transactions for this issuer
Get financial reports for this company